Europe direct-to-consumer (DTC) laboratory testing market is projected to reach $1.59 billion by 2030


Posted May 23, 2024 by richas

‘Europe DTC Laboratory Testing Market’ by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2030.
 
‘Europe DTC Laboratory Testing Market’ by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2030.

According to the latest publication from Meticulous Research®, the Europe direct-to-consumer (DTC) laboratory testing market is projected to reach $1.59 billion by 2030, growing at a CAGR of 10.8% from 2023 to 2030. This market growth is driven by several factors, including the rising incidence of chronic and sexually transmitted diseases, increased awareness of personal health management, and the benefits of DTC laboratory testing, such as convenience, affordability, and accessibility. Additionally, the increasing cost of healthcare, growing consumer interest in ancestry and genealogy testing, and the rising elderly population contribute to market expansion. Opportunities for further growth include the growing adoption of telehealth, market expansion in emerging economies, and increased penetration of pharmacogenomic testing in DTC laboratory services.

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/europe-dtc-laboratory-testing-market-5641

Genetic data privacy concerns, misinterpretation of test results, and the lack of professional medical counseling pose challenges for the Europe direct-to-consumer (DTC) laboratory testing market. Additionally, issues with sample integrity and interference, regulatory concerns, lack of reimbursement, and a limited test portfolio compared to conventional laboratory testing are factors that restrain the market's growth.

The Europe direct-to-consumer laboratory testing market is segmented by Application (Genetic Testing [Ancestry/Genealogy, Disease/Risk Assessment {Cancer, Cardiovascular Diseases, Neurological Diseases, & Other Applications}, Carrier Status, Other Genetic Tests], Diabetes Testing, Routine Clinical Testing, Thyroid Function Testing, Sexually Transmitted Disease Testing, and Other Applications), Sample Type (Blood, Saliva, Urine, and Other Samples) and Geography. The study also evaluates industry competitors and analyzes the regional and country-level markets.

Download Sample Report Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5641

Among applications, in 2023, The genetic testing segment is expected to hold the largest share of the market. This dominance is attributed to the growing appeal of DTC genetic testing for exploring family health history and assessing disease risks, the introduction of new DTC genetic tests for various applications, and the increasing interest in ancestry and lineage among people in developed countries.

Among sample types, The blood segment is expected to hold the largest share of the market. This is due to the benefits of blood samples, including the high reliability of results, the wide range of available test options, and the convenience of at-home blood collection services.

Request for Sample: https://www.meticulousresearch.com/request-sample-report/cp_id=5641


European geographies: Germany, the U.K., France, Spain, Italy, Switzerland, Netherlands, Belgium, Denmark, Ireland, and the Rest of Europe. In 2023, the U.K. is expected to account for the largest share of the Europe direct-to-consumer laboratory testing market. U.K.’s major market share is attributed to increased consumer awareness, high disposable income, and the rising incidence of chronic & sexually transmitted diseases.
Buy Now: https://www.meticulousresearch.com/Checkout/75217288

Key Players:
The key players profiled in the Europe direct-to-consumer laboratory testing market report are LetsGetChecked, Inc. (U.S.), Laboratoire CERBA (France), 23andMe Holding Co. (U.S.), Medichecks.com Ltd. (U.K.), Cerascreen Biotech LLC (U.K.), Living DNA Ltd (U.K.), SelfDiagnostics Deutschland GmbH (Germany), SYNLAB International GmbH (Germany), Natrix S.r.l. (Italy), and Mainz Biomed Germany GmbH (Germany).

Key questions answered in the report-
• Which are the high-growth market segments in terms of direct-to-consumer laboratory testing by application, sample, and geography?
• What was the historical market for direct-to-consumer laboratory testing across Europe?
• What are the market forecasts and estimates for the period 2023–2030?
• What are the major drivers, restraints, opportunities, and challenges in the Europe direct-to-consumer laboratory testing market?
• Who are the major players in the Europe direct-to-consumer laboratory testing market?
• What is the competitive landscape, and who are the market leaders in the Europe direct-to-consumer laboratory testing market?
• What are the recent developments in the Europe direct-to-consumer laboratory testing market?
• What are the different strategies adopted by the major players in the Europe direct-to-consumer laboratory testing market?
• What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By richa
Country India
Categories Health
Last Updated May 23, 2024